Considered compounds. Documented standards.Explore our standard
The SourceRESEARCH, REFINED.
TB500 20mg vial

Recovery research

TB500

20 mg / $140.00

TB-500 is a synthetic, N-acetylated heptapeptide corresponding to the actin-binding domain (residues 17–23) of Thymosin Beta-4, a ubiquitous actin-regulating protein of the β-thymosin family.

Available formats

1

Availability and final pricing are checked at checkout.

Product documentation

For laboratory research use only. Not for human consumption.

A closer look

The details
behind the compound.

Overview

TB-500 is a synthetic, N-acetylated heptapeptide corresponding to the actin-binding domain (residues 17–23) of Thymosin Beta-4, a ubiquitous actin-regulating protein of the β-thymosin family. It retains the LKKTETQ motif that defines the parent molecule's interaction with the cytoskeleton.

It is a familiar reference within the recovery category, studied for its role in cell motility and tissue organization, and frequently examined alongside complementary repair-signaling peptides.

Molecular weight
889.0 g/mol
CAS number
885340-08-9
Laboratory documentation

A laboratory report is not available in the current product record for this format.

Research references

Philp D, et al. Thymosin β4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair. Wound Repair Regen. 2003.

Esposito S, et al. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4. Drug Test Anal. 2012.

Storage & handling

Store the lyophilized powder at −20°C for long-term stability. Reconstituted solution is held at 2–8°C with a limited shelf life; avoid repeated freeze-thaw cycles.

The Source